≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_TONGUENAS_EXALLC for full statistics.

Malignant neoplasm of other and unspecified parts of tongue

DOID Endpoint Browser

C3_TONGUENAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C02
  • Cause of death: ICD-9 — 141
  • Cause of death: ICD-8 — 141
  • Cause of death: excluded ICD-9 — 1410A
  • Cause of death: excluded ICD-8 — 1410
  • Cancer registry: Topography ICD-O-3 — C02
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

481

4. Check minimum number of events

None

481

5. Include endpoints

None

481

6. Filter based on genotype QC (FinnGen only)

481

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of other and unspecified parts of tongue based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 481 214 267
Unadjusted period prevalence (%) 0.10 0.07 0.12
Median age at first event (years) 63.41 61.74 64.75

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
447
Matched controls
4472
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
10903.7
323.0
374
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
282.5
319.9
297
31
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
+∞
251.6
217
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
1381.7
245.4
217
*
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
+∞
162.7
146
*
EJB40
NOMESCO Finland
Hemiglossectomy
+∞
156.7
141
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
330.4
124.9
121
5
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
112.6
122.1
129
16
GBB00
NOMESCO Finland
Tracheostomy
143.8
121.4
125
12
JDB10
NOMESCO Finland
Percutaneous gastrostomy
85.5
104.8
115
18
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
612.2
101.9
97
*
130
Kela drug reimbursment
Malignant tumour
13.6
91.9
175
201
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
55.9
88.5
104
24
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
63.1
82.5
95
19
EP1AE
NOMESCO Finland
Neck ultrasound examination
16.0
77.0
132
114
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
852.8
75.5
72
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
134.5
74.6
78
7
K13.29
ICD-10 Finland
Indefinite leukoplakia
56.3
70.7
83
18
SAA03
NOMESCO Finland
Extended examination of mouth
5.8
65.1
292
1100
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
24.3
63.9
92
47
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
19.9
63.4
98
62
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.6
62.8
276
1000
C02.2
ICD-10 Finland
Malignant neoplasm: Ventral surface of tongue
+∞
60.8
57
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
14.6
59.1
104
91
A07AA02
ATC
nystatin; oral
10.3
53.6
113
142
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
+∞
52.1
49
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
14.2
52.1
92
80
WX408
NOMESCO Finland
General anesthesy, balanced
4.9
51.1
225
760
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
79.6
50.4
56
8
EBA15
NOMESCO Finland
Extraction of large number of teeth
15.4
50.0
85
67
C02.1
ICD-10 Finland
Malignant neoplasm: Border of tongue
+∞
47.8
45
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
11.4
46.9
92
99
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
6.7
46.8
134
267
N02AA05
ATC
oxycodone; systemic
5.5
44.4
156
399
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
49.9
44.3
53
12
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.3
42.2
93
123
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
63.8
40.1
46
8
SXA10
NOMESCO Finland
Epithel biopsy of mouth
32.5
39.7
52
18
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
+∞
38.1
36
*
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
+∞
37.0
35
*
K13.78
ICD-10 Finland
Other change in the oral mucosa
19.8
36.9
56
32
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
189.3
34.2
35
*
R4190
NOMESCO Finland
Nutritional therapy
13.2
32.4
58
50
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
347.1
32.3
32
*
K13.20
ICD-10 Finland
Idiopathic leukoplakia
41.3
30.8
38
10
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.2
30.2
250
1265
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.0
29.7
65
83
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
39.0
28.8
36
10
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
25.0
27.9
39
17
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
27.7
129
411
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
27.4
26
*
EBA10
NOMESCO Finland
Surgical removal of tooth
4.7
25.9
96
244
SBB10
NOMESCO Finland
Teeth copy
7.5
25.8
63
95
SXC03
NOMESCO Finland
Other oral or dental procedure
24.3
25.6
36
16
PJA12
NOMESCO Finland
Sentinel node biopsy
5.5
25.3
80
170
EBB10
NOMESCO Finland
Insertion of dental implant
21.1
25.2
37
19
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
51.5
24.6
29
6
WX402
NOMESCO Finland
General anaesthesia
3.7
24.5
126
431
EKA10
NOMESCO Finland
Biopsy of cheek
11.0
23.9
46
46
EBB15
NOMESCO Finland
Insertion of dental implant abutment
28.6
23.9
32
12
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
23.7
95
260
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
23.5
251
1410
ZXE40
NOMESCO Finland
More than seven and less than nine hours
11.8
23.2
43
40
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
22.2
22.9
33
16
EDB00
NOMESCO Finland
Partial excision of mandible
88.1
22.9
25
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
126.5
22.8
24
*
K14.9
ICD-10 Finland
Disease of tongue, unspecified
47.7
22.6
27
6
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
55.0
22.3
26
5
ECA20
NOMESCO Finland
Biopsy of gingiva
21.4
22.0
32
16
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
84.4
21.9
24
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
230.7
21.8
22
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
5.9
21.7
63
120
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
10.0
21.4
43
47
D10.12
ICD-10 Finland
Bone tumor of the tip of the tongue
52.8
21.3
25
5
ZZA00
NOMESCO Finland
Split skin graft
8.9
21.3
46
57
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
22.9
21.1
30
14
WF002
NOMESCO Finland
Radical radiotherapy
6.0
21.0
60
112
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
21.0
20
*
WX110
NOMESCO Finland
Local anesthesy
2.8
20.9
337
2339
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
115.4
20.7
22
*
D20
ICPC
Mouth/tongue/lip symptom/complaint
6.8
20.6
53
86
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
14.6
20.4
34
25
8070/3-C02.2
ICD-O-3
Squamous cell carcinoma, NOS, of ventral surface of tongue, NOS
+∞
19.9
19
*
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
+∞
19.9
19
*
ZXC10
NOMESCO Finland
Use of laser
10.3
19.3
38
40
A01AB09
ATC
miconazole; local oral
4.2
19.3
78
213
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
6.1
19.0
53
96
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
5.0
18.9
63
141
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
16.2
18.2
29
19
R4130
NOMESCO Finland
Speech therapy
10.4
18.0
35
36
EJC99
NOMESCO Finland
Other reconstructive operations on tongue and floor of mouth
+∞
17.8
17
*
4392
FHL
Tongue and / or Mouth resection or excision
+∞
17.8
17
*
SBA00
NOMESCO Finland
Microbiological examinations
8.3
17.5
39
51
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
17.3
129
559
SXC05
NOMESCO Finland
Other oral or dental procedure
6.4
17.2
46
79
TJD20
NOMESCO Finland
Change of gastrostomy tube
52.1
17.1
20
*
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
11.4
16.7
31
29
R13
ICD-10 Finland
Dysphagia
4.6
16.5
60
147
SAA02
NOMESCO Finland
Basic examination of mouth
2.3
16.1
299
2067
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.4
16.1
49
99
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
6.7
16.1
41
66
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.9
15.9
45
83
R4110
NOMESCO Finland
Physiotherapy
2.5
15.7
155
781
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
15.7
15
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
15.7
15
*
1412A
ICD-9 Finland
Malignant neoplasm of tongue, Tip and lateral border of tongue
+∞
15.7
15
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.8
15.7
54
125
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.5
15.6
156
789
ZX070
NOMESCO Finland
Intensity modified radiotherapy
7.8
15.3
35
48
T05
ICPC
Feeding problem of adult
24.4
15.2
21
9
K13.22
ICD-10 Finland
Erythroplakia of oral epithelium, including tongue
46.7
15.2
18
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
21.9
14.8
21
10
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.1
14.6
58
155
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
154.8
14.5
15
*
B37.08
ICD-10 Finland
Other candidal stomatitis
23.2
14.3
20
9
K12.10
ICD-10 Finland
Stomatitis NOS
44.0
14.2
17
*
Z51.5
ICD-10 Finland
Palliative care
4.2
13.9
55
146
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
55.1
13.9
16
*
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
11.4
13.7
25
23
D10.10
ICD-10 Finland
Benign tumor at the base of the tongue
144.1
13.5
14
*
D83
ICPC
Mouth/tongue/lip disease
41.4
13.2
16
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.3
13.1
31
45
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
3.6
13.1
61
187
J02AC01
ATC
fluconazole; systemic
2.2
13.1
180
1049
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
29.3
13.0
17
6
UJC01
NOMESCO Finland
Scopy of lower throat
19.8
13.0
19
10
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
13.0
89
360
SPF30
NOMESCO Finland
Soling for prothesis
8.2
12.8
28
36
K11.70
ICD-10 Finland
Hypoptyalism
18.0
12.6
19
11
C04.9
ICD-10 Finland
Malignant neoplasm: Floor of mouth, unspecified
+∞
12.6
12
*
4707
FHL
Dissection Colli radicalis
+∞
12.6
12
*
EKB00
NOMESCO Finland
Excision of lesion of cheek
25.1
12.5
17
7
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
133.5
12.5
13
*
EBA00
NOMESCO Finland
Extraction of tooth
2.2
12.4
172
1000
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
12.2
73
269
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.5
12.1
23
23
K14.61
ICD-10 Finland
Glossodynia
13.9
12.0
20
15
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.0
12.0
33
59
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.2
12.0
32
55
WZC30
NOMESCO Finland
Teaching
2.8
11.9
85
350
ED1AA
NOMESCO Finland
Mandipular X-ray examination
17.0
11.8
18
11
ZX095
NOMESCO Finland
Combined chemoradiotherapy
17.0
11.8
18
11
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
19.6
11.7
17
9
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
66.7
11.7
13
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.8
11.7
39
88
K08.3
ICD-10 Finland
Retained dental root
3.6
11.6
54
165
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
23.6
11.6
16
7
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.0
11.6
47
128
EJB70
NOMESCO Finland
Extensive partial excision of floor of mouth and tongue
+∞
11.5
11
*
EJB50
NOMESCO Finland
Total glossectomy
+∞
11.5
11
*
C02.3
ICD-10 Finland
Malignant neoplasm: Anterior two-thirds of tongue, part unspecified
+∞
11.5
11
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
15.6
11.4
18
12
SPF20
NOMESCO Finland
Temporary soling for filling
15.6
11.4
18
12
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
10.0
11.4
22
23
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
36.0
11.3
14
*
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
44.5
11.0
13
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.8
10.7
35
77
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
61.5
10.7
12
*
A04AA02
ATC
granisetron; systemic, transdermal
3.7
10.6
46
133
A01AB04
ATC
amphotericin B; local oral
4.3
10.5
39
98
ZXE00
NOMESCO Finland
One hour or less
2.0
10.5
191
1220
EJC30
NOMESCO Finland
Reconstruction of tongue
+∞
10.5
10
*
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
12.4
10.4
18
15
L43.9
ICD-10 Finland
Lichen planus, unspecified
7.4
10.4
24
34
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
11.0
10.4
19
18
EB1WA
NOMESCO Finland
NA
19.3
10.3
15
8
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
19.3
10.3
15
8
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.9
10.1
42
117
ECB20
NOMESCO Finland
Oral alveoplasty
15.0
10.1
16
11
K05.31
ICD-10 Finland
Periodontitis pronounced
2.8
9.9
65
254
Z3226
NOMESCO Finland
Physiotherapist
2.3
9.9
98
480
L43.8
ICD-10 Finland
Other lichen planus
6.4
9.8
25
41
A06AD11
ATC
lactulose; oral
2.4
9.8
86
396
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
13.8
9.7
16
12
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
8.7
9.7
20
24
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
11.7
9.6
17
15
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
5.6
9.5
27
51
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
18.0
9.5
14
8
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
8.3
9.4
20
25
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
12.7
9.4
16
13
EJB60
NOMESCO Finland
Partial excision of floor of mouth
+∞
9.4
9
*
K14.09
ICD-10 Finland
Glossit UNS
+∞
9.4
9
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
9.4
9
*
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
9.4
9
*
Z50.5
ICD-10 Finland
Speech therapy
9.0
9.4
19
22
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
16.0
9.1
14
9
ENA10
NOMESCO Finland
Biopsy of pharynx
37.5
9.1
11
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.9
8.7
303
2368
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
51.0
8.7
10
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
51.0
8.7
10
*
JDB00
NOMESCO Finland
Gastrostomy
51.0
8.7
10
*
K13
ICD-10 Finland
Other diseases of lip and oral mucosa
51.0
8.7
10
*
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
7.2
8.6
20
29
WX872
NOMESCO Finland
Intensive care
3.7
8.6
36
102
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
20.5
8.5
12
6
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
20.5
8.5
12
6
4394
FHL
Glossectomy or hemiglossectomy
+∞
8.4
8
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
8.4
8
*
SPA02
NOMESCO Finland
Preparation for dental prosthetics
7.3
8.3
19
27
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.7
8.3
27
60
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
8.3
179
1190
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
8.2
101
541
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
8.2
46
161
D77
ICPC
Malignant digestive neopl other/NOS
34.0
8.1
10
*
WX002
NOMESCO Finland
Sedation and analgesia
2.1
8.1
107
591
K02.1
ICD-10 Finland
Caries of dentine
1.8
8.0
243
1795
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
7.9
51
198
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
8.7
7.9
16
19
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.0
7.9
45
161
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
7.9
121
710
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
3.8
7.8
32
89
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
45.8
7.7
9
*
H03AA01
ATC
levothyroxine sodium; systemic
2.0
7.7
105
586
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
12.1
7.6
13
11
L43.0
ICD-10 Finland
Hypertrophic lichen planus
25.5
7.6
10
*
ECA30
NOMESCO Finland
Excision of lesion of gingiva
9.1
7.6
15
17
H02AB02
ATC
dexamethasone; systemic
2.5
7.5
58
249
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
7.5
55
230
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.7
7.5
24
53
K14.88
ICD-10 Finland
Other diseases of tongue
81.4
7.4
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
7.3
179
1223
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
+∞
7.3
7
*
B37.02
ICD-10 Finland
Chronic hyperplastic candidal stomatitis
+∞
7.3
7
*
8071/3-C02.1
ICD-O-3
Squamous cell carcinoma, keratinizing, NOS, of border of tongue
+∞
7.3
7
*
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
+∞
7.3
7
*
WX707
NOMESCO Finland
Fiberoscopic intubation
16.1
7.3
11
7
K13.21
ICD-10 Finland
Leukoplakia caused by tobacco
30.5
7.2
9
*
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
30.5
7.2
9
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
30.5
7.2
9
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
7.1
197
1396
ZXE90
NOMESCO Finland
More than 22 hours
12.3
7.1
12
10
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.9
7.1
41
148
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
5.1
7.1
21
43
ZXA05
NOMESCO Finland
Left side
1.9
7.0
127
785
WX730
NOMESCO Finland
Conventional respirator
6.5
7.0
17
27
SCA03
NOMESCO Finland
Preventive oral health care, extensive
3.7
6.9
29
83
N02BE01
ATC
paracetamol; systemic, rectal
2.0
6.9
381
3323
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.1
6.8
25
64
K14.69
ICD-10 Finland
Tongue pain UNS
17.0
6.8
10
6
A01AB10
ATC
natamycin; local oral
4.6
6.7
22
50
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
6.7
36
125
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.7
6.7
21
46
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.5
6.5
18
34
ZXD05
NOMESCO Finland
Urgent procedure
1.8
6.5
137
888
SPA62
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 7 or more units
70.8
6.4
7
*
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
70.8
6.4
7
*
GD6AD
NOMESCO Finland
CT of chest and neck
70.8
6.4
7
*
8070/3-C06.0
ICD-O-3
Squamous cell carcinoma, NOS, of cheeck mucosa
70.8
6.4
7
*
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.9
6.4
110
663
XQ902
NOMESCO Finland
Other photography
14.6
6.4
10
7
Z2221
NOMESCO Finland
Medical doctor
1.8
6.4
125
792
R02AD02
ATC
lidocaine; local oral
5.7
6.4
17
31
EHA10
NOMESCO Finland
Biopsy of palate
11.2
6.3
11
10
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
18.3
6.3
9
5
D37.09
ICD-10 Finland
Lip, oral cavity and pharynx
18.3
6.3
9
5
EJ2S1
NOMESCO Finland
Photography of oral mucosa
18.3
6.3
9
5
K05.30
ICD-10 Finland
Periodontitis complex
2.1
6.3
71
368
D00.06
ICD-10 Finland
Cancer in situ in another part of the tongue
+∞
6.3
6
*
C02
ICD-10 Finland
Malignant neoplasm of other and unspecified parts of tongue
+∞
6.3
6
*
Z2446
NOMESCO Finland
Social worker
3.0
6.2
35
123
RD210
NOMESCO Finland
NA
6.4
6.2
15
24
EBA12
NOMESCO Finland
Complicated surgical removal of tooth
5.9
6.2
16
28
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.7
6.2
155
1056
S18
ICPC
Laceration/cut
1.7
6.1
191
1386
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
5.0
6.1
18
37
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.8
6.1
39
150
S01.50
ICD-10 Finland
Open wound in oral cavity
8.8
6.1
12
14
PJA10
NOMESCO Finland
Exploration of lymph nodes
10.2
6.1
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
83
15
66.66
149.45
3.8
1.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
208
417
8.03
109.68
2.1
2.2
g/l
0.2
0.2
2.35
200
393
(4035726)
149
365
5.47
59.96
1.5
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
56
49
12.80
55.21
1.8
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
328
1553
4.50
54.38
4.2
2.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
182
664
3.80
41.68
5.2
3.3
mmol/l
0.8
0.8
6.43
171
624
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
218
983
3.23
34.40
2.8
2.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
39
43
9.78
32.55
1.3
1.5
mosm/kgh2o
285.2
276.0
1.45
39
31
(3024561) Albumin [Mass/volume] in Serum or Plasma
313
1776
3.18
32.41
4.4
4.9
g/l
35.3
35.3
0.07
298
1662
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
128
439
3.61
31.11
1.6
1.8
%
1.8
1.5
1.57
115
377
(3044640) Blood type and Crossmatch panel - Blood
251
1285
2.99
30.79
3.0
2.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
54
99
6.02
28.87
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
134
495
3.37
28.77
1.5
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
314
1873
2.95
28.08
4.1
4.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
247
1348
2.71
25.42
3.5
3.5
mmol/l
2.4
2.4
1.65
232
1176
(3032080) INR in Blood by Coagulation assay
285
1747
2.55
21.99
6.5
9.6
inr
1.1
1.3
5.08
77
501
(3007853) Bacteria identified in Skin by Aerobe culture
110
463
2.78
18.00
2.0
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
112
501
2.61
16.10
1.8
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
335
2406
2.29
15.49
7.2
5.0
mmol/l
6.6
6.8
1.55
328
2265
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
304
2185
2.06
12.86
6.7
6.5
umol/l
10.3
11.6
2.24
289
2078
(3023368) Bacteria identified in Blood by Culture
190
1158
2.06
12.70
4.7
4.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
173
1022
2.08
12.55
1.6
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
269
1880
1.98
11.97
7.9
6.2
mmol/l
1.2
1.2
1.85
254
1700
(3042936) Bacteria identified in Isolate by Culture
118
616
2.21
11.67
2.0
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
308
2275
1.98
11.45
9.5
9.3
e9/l
4.2
4.2
0.01
278
2018
(3003396) Base excess in Arterial blood by calculation
101
508
2.25
10.87
8.8
7.9
mmol/l
1.5
1.2
0.35
83
409
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
75
341
2.42
10.15
1.8
2.8
ng/l
241.2
196.3
0.27
68
307
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
196
1287
1.88
9.98
2.5
3.5
u/l
36.0
32.8
0.35
188
1227
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
277
2031
1.86
9.89
8.5
7.1
mmol/l
1.2
1.2
1.46
237
1716
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
93
472
2.20
9.72
2.0
2.9
umol/l
12.2
8.7
0.36
87
423
(40758558) Short blood count panel - Blood
158
980
1.91
9.50
7.5
6.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
190
1281
1.80
8.58
5.3
5.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
70
333
2.29
8.50
3.2
2.7
ml/min/173m2
70.1
65.3
0.45
32
139
(3006315) Basophils [#/volume] in Blood
263
1954
1.76
8.46
5.4
5.6
e9/l
0.0
0.0
0.19
226
1710
(3014576) Chloride [Moles/volume] in Serum or Plasma
100
554
2.02
8.23
7.6
7.0
mmol/l
103.9
104.1
0.12
100
539
(3001604) Monocytes [#/volume] in Blood
261
1945
1.75
8.22
5.5
5.5
e9/l
0.6
0.6
0.45
224
1695
(3018418) pH of Serum or Plasma
183
1234
1.78
8.17
4.7
4.2
ph
7.4
7.4
0.57
36
238
(3013115) Eosinophils [#/volume] in Blood
267
2014
1.73
7.95
5.7
5.7
e9/l
0.2
0.2
0.74
234
1780
(3006504) Eosinophils/100 leukocytes in Blood
247
1828
1.72
7.84
5.7
5.6
%
3.0
2.8
0.39
236
1708
(3019198) Lymphocytes [#/volume] in Blood
263
1986
1.72
7.71
5.5
5.6
e9/l
1.8
1.9
0.23
229
1761
(3019069) Monocytes/100 leukocytes in Blood
247
1836
1.71
7.65
5.9
5.9
%
8.8
8.8
0.00
235
1725
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
218
1569
1.71
7.58
2.4
2.2
nmol/l
77.0
77.1
0.02
202
1383
(3000991) Gas panel - Venous blood
70
349
2.18
7.57
10.5
9.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
372
3114
1.86
7.44
8.9
7.8
u/l
79.3
79.3
0.00
364
2918
(3002030) Lymphocytes/100 leukocytes in Blood
249
1868
1.69
7.35
5.8
5.8
%
23.8
27.0
3.50
236
1742
(3022096) Basophils/100 leukocytes in Blood
239
1775
1.69
7.32
5.8
5.6
%
0.6
0.7
0.17
227
1659
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
314
2516
1.71
7.15
3.3
3.2
u/l
60.6
53.1
0.68
298
2335
(3018010) Neutrophils/100 leukocytes in Blood
244
1839
1.66
6.93
5.6
5.6
%
60.5
57.6
2.37
231
1728
(3021589) Normoblasts [#/volume] in Blood
225
1699
1.61
6.08
12.7
10.1
e9/l
0.0
0.0
0.60
181
1408
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
27
4.92
6.00
1.3
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
107
679
1.74
5.61
1.8
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
75
435
1.86
5.29
4.2
3.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
139
2.48
5.26
1.7
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
48
238
2.13
5.26
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
35
152
2.40
5.23
1.8
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
340
2894
1.60
5.09
4.5
3.8
pmol/l
14.8
14.9
0.49
306
2583
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
178
1315
1.56
5.04
2.6
3.1
ng/l
935.0
1343.7
1.77
162
1119
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
428
3881
1.93
4.97
24.0
15.5
mg/l
33.7
25.1
6.10
387
3103
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
57
308
1.97
4.97
1.7
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
94
598
1.71
4.84
2.7
2.4
g/l
2.2
2.3
0.67
86
558
(3022948) Iron [Moles/volume] in Serum or Plasma
100
650
1.68
4.76
2.7
2.4
umol/l
12.1
13.0
0.53
95
602
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
342
3828
0.63
4.73
4.4
4.6
mmol/l
1.5
1.4
0.84
309
3486
(3003181) Sodium [Moles/volume] in Urine
20
70
2.94
4.55
1.6
1.4
mmol/l
71.3
63.7
0.26
15
65
(3018677) aPTT in Platelet poor plasma by Coagulation assay
103
684
1.64
4.50
1.7
1.9
s
30.5
29.5
1.11
103
661
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
139
1003
1.54
4.26
2.3
2.1
mg/l
2.6
3.1
2.89
127
863
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
48
259
1.95
4.21
1.8
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
112
775
1.58
4.11
3.2
3.1
mmol/l
2.5
2.5
2.19
103
685
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
88
574
1.65
4.10
2.8
2.4
%
22.9
22.6
0.05
76
494
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
349
3861
0.65
4.09
4.3
4.7
mmol/l
4.5
4.6
1.03
315
3535
(3013707) Erythrocyte sedimentation rate by Westergren method
336
2918
1.50
4.02
3.7
4.1
mm/h
14.6
12.7
1.37
318
2669
(1761868) Lipid panel - Serum or Plasma
91
1308
0.62
3.96
2.9
3.1
—
—
—
0
0
(3044889) 12 lead EKG panel
327
2829
1.49
3.94
4.2
4.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
236
1.95
3.94
8.2
9.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
359
3939
0.65
3.88
4.8
5.2
mmol/l
2.5
2.7
2.55
327
3593
(3021960) Folate [Moles/volume] in Serum or Plasma
136
996
1.51
3.84
1.5
1.5
nmol/l
21.0
20.8
0.07
118
830
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
144
2.16
3.61
3.3
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
112
802
1.52
3.49
3.0
2.8
mosm/kgh2o
512.6
563.0
1.88
99
686
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
64
2.72
3.43
1.2
1.2
—
—
—
0
0
(4010399)
50
295
1.78
3.35
1.3
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
83
563
1.57
3.29
16.0
24.3
inr
1.3
1.3
0.03
14
73
(3019309) Folate [Moles/volume] in Red Blood Cells
109
786
1.50
3.27
1.8
1.7
nmol/l
1184.2
1221.6
0.15
75
591
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
337
3708
0.70
3.18
4.1
4.2
mmol/l
1.3
1.3
0.11
309
3360
(3000850) Epithelial cells [#/volume] in Urine
116
855
1.47
3.11
2.7
2.6
e6/l
6.7
4.5
0.62
103
754
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
29
3.50
3.06
1.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
16
5.06
3.06
1.1
2.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
159
1248
1.41
3.03
3.7
3.3
e6/l
136.3
102.7
0.12
126
965
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
17
4.77
2.93
1.1
2.2
—
—
—
0
0
(3000492) Spirometry study
54
346
1.63
2.71
1.5
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
10
6.06
2.70
1.3
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
6
10
6.06
2.70
1.3
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
10
6.06
2.70
1.0
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
140
1099
1.39
2.62
3.6
3.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
145
1145
1.38
2.62
3.6
3.2
e6/l
0.6
0.6
0.04
115
861
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
114
2.07
2.60
1.5
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
91
662
1.46
2.59
3.4
3.1
e6/l
2.8
1.8
0.36
51
372
(3019060) Gas panel - Arterial blood
47
295
1.66
2.56
5.6
4.8
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
12
44
2.77
2.56
1.4
1.4
e6/l
499.5
1666.3
—
6
29
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
44
2.77
2.56
1.1
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
129
1.99
2.55
2.8
2.6
u/ml
0.3
0.3
0.01
15
68
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
106
798
1.42
2.52
3.5
3.9
ng/l
317.5
275.0
0.08
91
666
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
21
3.86
2.47
1.1
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
173
1418
1.34
2.44
4.4
3.8
e6/l
68.1
76.8
0.13
132
1034
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
397
3689
1.44
2.37
22.7
14.5
ml/min/173m2
83.3
78.2
5.43
356
3052
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
32
185
1.78
2.34
1.5
2.1
g/l
1.5
1.5
0.08
27
160
(3001122) Ferritin [Mass/volume] in Serum or Plasma
190
1590
1.32
2.29
3.0
2.6
ug/l
158.7
142.1
0.44
180
1458
(3020891) Body temperature
29
165
1.81
2.24
7.6
4.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
30
3.04
2.15
1.4
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
17
82
2.11
2.09
3.0
3.8
mmol/l
3.2
2.4
0.96
11
55
(3051651) Icteric interference index of Serum or Plasma
9
31
2.94
2.08
3.2
3.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
196
1668
1.30
2.04
2.1
2.0
pmol/l
96.5
93.7
0.31
97
855
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
9
32
2.85
2.01
1.6
1.5
u/l
50.0
31.5
—
9
26
(3019550) Sodium [Moles/volume] in Serum or Plasma
429
4073
1.49
2.01
27.4
18.2
mmol/l
138.5
139.7
11.88
423
3966
(40761511) CBC panel - Blood by Automated count
424
4023
1.46
1.92
21.1
14.6
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
50
0.00
1.89
0.0
1.3
—
8.1
—
0
35
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
51
0.00
1.89
0.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
22
3.21
1.88
1.3
2.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
429
4086
1.46
1.83
27.2
18.3
mmol/l
3.9
4.0
3.24
422
3976
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
176
1495
1.28
1.82
3.5
3.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
377
3521
1.33
1.79
5.5
4.6
mu/l
2.5
2.3
0.16
350
3170
(3035637) Corticotropin [Mass/volume] in Plasma
10
42
2.41
1.68
1.5
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
361
3830
0.77
1.67
4.5
4.8
mmol/l
6.0
6.0
0.22
321
3472
(40760888) Immunoglobulin light chains.free panel - Serum
19
105
1.84
1.65
2.5
4.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
67
502
1.39
1.65
2.0
2.7
%
1.8
1.8
0.01
61
454
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
32
206
1.59
1.64
1.0
1.2
iu/ml
100.5
177.1
0.98
11
77
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
54
390
1.43
1.63
2.6
2.4
u/l
29.5
33.6
0.32
48
330
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
65
486
1.39
1.62
1.9
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
50
2.23
1.58
1.1
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
489
1.38
1.56
1.9
1.9
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
86
1075
0.76
1.56
1.6
1.7
mmol/l
1.3
1.4
0.72
73
892
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
71
2.00
1.55
1.7
3.0
e9/l
4.8
4.6
0.16
14
71
(3051611) Lipemic interference index of Serum or Plasma
10
44
2.30
1.54
3.4
3.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
45
0.00
1.50
0.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
237
2122
1.23
1.47
2.3
2.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
52
2.14
1.45
1.1
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
73
1.95
1.45
2.1
3.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
73
1.95
1.45
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
73
1.95
1.45
1.6
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
73
1.95
1.45
1.7
3.6
%
64.3
58.8
0.70
14
73
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
16
3.15
1.44
2.0
3.9
u/l
172.2
223.7
—
5
16
(3025130) Human papilloma virus identified in Specimen
7
29
2.43
1.39
1.6
2.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
53
2.10
1.39
1.5
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
23
2.63
1.37
1.3
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
6
23
2.63
1.37
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
113
1343
0.79
1.36
3.9
4.3
%
20.2
21.4
0.31
49
642
(3033799) Differential panel - Peritoneal fluid
5
17
2.96
1.36
2.8
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
21
128
1.67
1.35
1.4
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
54
2.06
1.33
1.5
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
54
2.06
1.33
1.5
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
54
2.06
1.33
1.5
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
54
2.06
1.33
1.5
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
55
2.02
1.28
1.5
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
87
706
1.28
1.27
3.2
2.9
e6/l
0.9
1.0
0.06
49
409
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
13
228
0.56
1.27
1.4
1.3
—
38.3
—
0
15
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
129
1498
0.81
1.25
3.4
4.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
36
2.24
1.24
1.5
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
45
2.02
1.24
1.4
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
19
2.65
1.22
1.4
1.1
nmol/l
117.0
157.3
—
5
19
(3002385) Erythrocyte distribution width [Ratio]
338
3175
1.22
1.18
28.6
18.9
%
13.9
13.8
0.57
331
3114
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
57
1.95
1.18
1.1
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
118
1.64
1.16
4.9
3.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
33
0.00
1.16
0.0
1.1
—
0.1
—
0
5
(3019230) Fractional oxyhemoglobin in Venous blood
13
72
1.83
1.16
1.5
2.3
%
54.8
61.9
0.47
13
72
(3019225) pH of Specimen
53
407
1.34
1.16
3.9
4.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
20
2.52
1.15
1.2
12.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
16
257
0.61
1.14
2.5
2.5
—
16.0
—
0
11
(3044007) Cell count panel - Peritoneal fluid
5
21
2.40
1.09
2.0
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
49
377
1.33
1.07
4.1
3.8
mmol/l
4.1
2.0
2.53
40
305
(3022806) Fractional oxyhemoglobin in Capillary blood
10
53
1.91
1.02
2.4
2.2
%
85.6
89.5
—
10
53
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
427
4134
1.29
1.00
12.5
10.9
u/l
25.6
26.4
0.46
414
3974
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
29
398
0.71
0.99
1.5
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
61
1.82
0.99
1.5
3.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
49
1.85
0.99
1.4
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
211
0.61
0.99
2.7
3.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
51
400
1.31
0.98
2.2
2.5
ug/l
5.5
7.0
0.45
43
351
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
23
2.19
0.98
1.4
1.6
—
—
—
0
0
(4268621)
7
36
1.96
0.97
2.0
2.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
427
4138
1.28
0.96
27.3
18.4
umol/l
75.6
80.2
1.98
427
4138
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
141
1243
1.19
0.96
2.1
2.1
u/l
160.3
228.1
1.36
135
1163
(3020682) Albumin/Creatinine [Ratio] in Urine
115
1316
0.83
0.93
4.0
4.0
mg/mmol
8.1
8.9
0.12
71
838
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
494
1.27
0.93
1.2
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
231
0.64
0.92
1.3
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
149
1665
0.85
0.92
4.5
5.0
ug/l
1.9
2.6
1.35
132
1493
(4062490)
8
42
1.92
0.89
1.0
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
80
1.64
0.85
1.5
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
80
1.64
0.85
1.2
1.2
—
—
—
0
0
(3012544) pH of Venous blood
49
391
1.28
0.85
3.6
3.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
31
1.95
0.84
1.3
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
45
1.79
0.84
1.5
1.5
—
—
—
0
0
(4306422)
8
45
1.79
0.84
1.1
1.3
—
—
—
0
0
(1002224) Polysomnography panel
8
140
0.56
0.84
1.1
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
145
1296
1.17
0.83
3.0
2.5
u/l
50.7
56.7
1.33
139
1207
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
73
1.66
0.82
1.4
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
39
304
1.31
0.81
3.6
4.4
%
0.0
0.1
0.66
11
88
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
280
0.70
0.79
1.6
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
41
323
1.29
0.79
3.6
4.3
%
0.2
0.2
0.00
12
103
(3047189) Immunofixation for 24 hour Urine
0
24
0.00
0.79
0.0
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
33
1.83
0.79
1.0
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
66
1.68
0.79
1.1
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
46
369
1.27
0.78
1.7
2.9
e9/l
67.0
71.7
0.40
39
290
(3026493) Urate [Moles/volume] in Serum or Plasma
96
1098
0.84
0.77
2.8
2.7
umol/l
14392.1
7870.7
0.37
77
932
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
588
0.80
0.77
1.2
1.3
u/ml
11.7
13.5
0.09
21
224
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
59
1.71
0.76
1.4
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
67
1.66
0.75
1.1
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
39
308
1.29
0.75
3.7
4.2
%
1.0
0.4
—
10
83
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
108
1.50
0.74
1.3
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
100
1.52
0.73
1.0
1.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
73
851
0.83
0.73
3.3
4.2
kg/l
1.0
1.0
—
6
113
(40768443) Skin Pathology biopsy report
23
168
1.39
0.73
1.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
36
283
1.29
0.72
1.8
2.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
177
1921
0.88
0.71
4.4
5.0
estimate
0.0
0.0
0.00
44
367
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
26
1.93
0.71
1.0
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
115
1286
0.86
0.70
3.2
3.1
mmol/l
6.2
7.6
2.62
93
1056
(3041096) Erythrocytes [Presence] in Urine by Automated
93
1056
0.85
0.69
3.2
3.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
176
1908
0.88
0.69
3.4
3.8
estimate
0.0
0.0
0.00
43
366
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
61
1.65
0.69
1.2
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
111
1241
0.86
0.68
3.3
3.3
mg/l
47.5
265.2
1.41
70
806
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
61
515
1.21
0.67
8.8
7.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
43
1.64
0.67
2.1
2.7
—
—
—
0
0
(4281824)
7
43
1.64
0.67
1.4
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
105
0.57
0.62
3.5
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
187
0.69
0.62
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
50
1.61
0.61
2.0
3.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
80
1.51
0.60
1.1
1.5
—
—
—
0
0
(4027681)
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
97
1.46
0.59
1.6
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
4.0
—
0
6
(3005322) IgE [Units/volume] in Serum or Plasma
15
208
0.71
0.59
1.1
1.2
u/ml
441.0
155.3
0.59
15
190
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
230
0.73
0.58
1.6
1.7
—
—
—
0
0
(44813793)
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
116
0.60
0.58
1.1
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
46
385
1.22
0.57
1.3
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
205
0.72
0.55
1.7
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
8
126
0.63
0.55
1.1
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
42
350
1.22
0.55
3.5
4.2
%
1.2
0.9
0.41
13
116
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
54
628
0.84
0.55
1.2
1.3
iu/ml
30.3
37.1
0.22
15
208
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
99
1.43
0.54
1.4
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
182
1945
0.90
0.54
3.4
3.8
estimate
0.0
0.0
0.00
43
349
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
425
1.20
0.54
1.4
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
108
1.40
0.53
1.5
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
91
1.44
0.53
1.6
3.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
62
1.46
0.53
1.8
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
96
862
1.14
0.53
1.6
1.6
mg/l
1.4
1.3
0.11
72
672
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
97
0.61
0.52
1.0
1.1
—
11.8
—
0
9
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
63
1.44
0.52
1.1
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
162
1.31
0.51
2.2
2.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
67
1.50
0.50
1.1
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
108
0.64
0.49
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
87
965
0.88
0.48
2.9
3.1
ug/l
0.8
0.8
0.35
55
649
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
46
1.53
0.48
3.9
2.8
nmol/l
1.6
6.4
—
7
46
(3013512) EKG study
135
1249
1.11
0.46
3.8
4.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
54
471
1.17
0.45
3.5
4.5
ug/l
5.1
35.6
1.10
48
400
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
51
1.38
0.44
3.4
3.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
30
248
1.22
0.44
3.4
2.4
e9/l
3.5
4.0
0.92
22
190
(42529406) Shigella sp [Presence] in Stool by Culture
9
127
0.70
0.44
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
104
1.36
0.43
1.2
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
56
1.44
0.42
1.3
2.3
pg
33.3
33.3
—
8
56
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
46
528
0.86
0.42
4.3
4.7
%
34.7
31.4
1.10
35
348
(3015183) Erythrocyte sedimentation rate
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.6
—
62.4
—
0
16
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
16
0.00
0.41
0.0
1.1
—
29.5
—
0
11
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.2
—
8.8
—
0
16
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
38
325
1.18
0.40
3.3
4.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
27
324
0.82
0.40
2.3
2.3
nmol/l
13.3
13.0
0.06
22
287
(3009542) Hematocrit [Volume Fraction] of Blood
353
3437
1.10
0.40
24.6
16.5
%
38.0
39.9
4.87
256
2346
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
18
0.00
0.40
0.0
1.3
—
1.6
—
0
11
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
18
0.00
0.40
0.0
1.2
—
7.5
—
0
18
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
97
1054
0.90
0.39
3.7
4.1
estimate
0.0
0.0
0.50
41
350
(40768797) Stomach Pathology biopsy report
63
564
1.13
0.38
1.7
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
67
1.35
0.38
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
98
1.34
0.38
1.4
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
174
1647
1.09
0.37
3.8
3.9
ng/l
34.9
39.3
0.27
135
1220
(1761482) Bacteria [#/volume] in Urine by Culture
8
116
0.68
0.37
3.5
4.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
279
2695
1.08
0.36
4.0
4.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
78
0.64
0.36
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
126
0.71
0.35
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
265
0.82
0.35
2.1
2.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
82
1.35
0.34
1.8
1.9
pmol/l
227.1
222.1
0.08
11
77
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
15
118
1.28
0.34
1.5
1.7
nmol/l
43.1
39.8
0.25
15
112
(3048689) Calprotectin [Mass/mass] in Stool
37
423
0.86
0.33
2.7
2.2
ug/g
361.0
140.3
0.61
31
343
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
25
210
1.20
0.33
2.4
2.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
240
0.83
0.31
1.3
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
93
1.30
0.30
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
1.0
1.1
g/l
1.5
1.5
—
7
52
(3021901) Oxygen saturation in Capillary blood
10
76
1.32
0.28
3.0
2.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
183
0.81
0.28
1.3
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
53
481
1.11
0.28
1.5
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
22
257
0.85
0.27
1.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
71
0.70
0.26
1.2
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
73
1.24
0.25
1.1
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
94
883
1.08
0.25
1.6
1.8
pmol/l
121333824.7
432.5
0.49
75
715
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
81
0.74
0.24
1.2
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
83
0.72
0.24
1.5
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
85
0.70
0.24
1.5
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
16
190
0.84
0.24
2.5
2.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
218
1.15
0.24
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
51
467
1.10
0.23
1.4
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
432
4275
1.10
0.23
33.5
22.7
e9/l
258.4
243.0
4.33
425
4162
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
179
0.83
0.23
1.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
432
4276
1.10
0.23
33.4
22.6
fl
92.4
91.4
4.01
427
4210
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.0
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
432
4277
1.10
0.22
33.3
22.6
pg
30.7
30.4
2.78
427
4210
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
124
0.80
0.22
2.9
2.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
432
4278
1.10
0.21
33.5
22.7
e12/l
4.2
4.5
22.31
424
4150
(3010813) Leukocytes [#/volume] in Blood
432
4278
1.10
0.21
33.5
22.7
e9/l
7.2
6.8
1.72
424
4149
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(4198724)
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
101
0.79
0.21
1.4
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
2.4
—
0
6
(40761535) Cells panel - Urine sediment
31
345
0.89
0.21
3.2
3.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
166
0.84
0.21
1.7
1.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.1
—
0.7
—
0
7
(3006462) Nitrate [Presence] in Urine
0
14
0.00
0.20
0.0
3.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
249.8
—
0
14
(3004616) Nuclear Ab [Presence] in Serum
6
49
1.23
0.20
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
51
1.18
0.19
1.5
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
25
280
0.89
0.19
1.3
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
174
0.86
0.18
1.4
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
61
1.15
0.17
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
110
1.19
0.17
1.5
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
71
1.13
0.16
7.6
2.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
77
0.78
0.15
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
78
0.77
0.15
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
78
0.77
0.15
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
90
0.77
0.14
1.6
2.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
366
3697
0.96
0.13
5.6
6.1
mmol/mol
38.7
40.5
3.82
345
3420
(3021879) Hepatitis B virus core Ab [Presence] in Serum
27
248
1.09
0.13
1.1
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
46
486
0.94
0.12
1.3
1.3
titre
716.7
472.4
0.26
12
111
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
124
1.13
0.11
1.9
2.6
ug/min
38.5
89.3
—
9
68
(4034850)
15
134
1.12
0.11
17.7
11.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
19
208
0.91
0.10
4.4
3.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
70
727
0.96
0.10
1.6
1.5
g/l
3.2
2.6
0.82
45
452
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
135
0.89
0.10
1.5
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
45
1.11
0.10
4.2
2.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
47
1.06
0.09
1.2
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
24
258
0.93
0.09
4.2
3.7
mmol/l
3.3
1.8
1.01
19
200
(3037121) Protein [Mass/volume] in Urine
16
145
1.11
0.09
2.3
3.5
g/l
0.1
0.2
—
9
57
(4146454)
5
48
1.04
0.09
4.4
2.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
61
0.82
0.08
1.8
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
10
88
1.14
0.08
1.2
1.2
mg/l
457.9
483.6
—
10
83
(3001019) Free T4 and TSH panel - Serum or Plasma
14
127
1.11
0.08
1.4
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
74
0.81
0.07
1.2
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
76
782
0.97
0.07
1.3
1.2
u/ml
1.8
1.4
0.23
22
218
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
85
0.82
0.07
1.0
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
183
0.93
0.06
3.5
3.1
u/ml
31.9
49.2
0.39
17
176
(4094501)
9
103
0.87
0.06
1.2
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
123
1209
1.02
0.06
2.8
3.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
83
849
0.97
0.06
4.0
4.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
104
1.06
0.01
1.4
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
43
434
0.99
0.00
1.3
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
88
883
1.00
0.00
3.1
3.8
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
2.0
—
0
8
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
1.3
—
0
8
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
27.0
—
0
8
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
3.8
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
66
0.91
0.00
1.7
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.2
1.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
51
0.98
0.00
1.4
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
6.7
—
7.3
—
0
6
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
72
0.97
0.00
1.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
13.4
—
0
6
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
61
0.98
0.00
1.7
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
1.2
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_TONGUENAS – Malignant neoplasm of other and unspecified parts of tongue

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).